ストックスクリーナーアプリを入手
108.75
2.63%
2.785
前日終値:
$105.96
開ける：
$106.01
24時間の取引高:
1.54M
Relative Volume:
0.58
時価総額：
$14.12B
収益：
$692.26M
当期純損益:
$-512.41M
株価収益率:
-25.65
EPS:
-4.24
ネットキャッシュフロー:
$-274.36M
1週間 パフォーマンス:
+0.89%
1か月 パフォーマンス:
+10.81%
6か月 パフォーマンス:
+127.69%
1年 パフォーマンス:
+185.35%
1日の値動き範囲:
$105.68
$109.59
1週間の範囲:
$103.36
$109.59
52週間の値動き範囲:
$29.91
$112.42
Guardant Health Inc Stock (GH) Company Profile
GH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
108.75 | 13.76B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
575.24 | 218.08B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.13 | 161.37B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.35 | 57.97B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.32 | 42.25B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
224.92 | 38.70B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-09-25 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 再開されました | Wells Fargo | Overweight |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-28 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-26 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-03-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-11-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 開始されました | Craig Hallum | Buy |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-04-28 | 再開されました | BTIG Research | Buy |
| 2022-02-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2022-02-24 | 繰り返されました | Citigroup | Buy |
| 2022-02-24 | 繰り返されました | Cowen | Outperform |
| 2022-02-24 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-24 | 繰り返されました | SVB Leerink | Outperform |
| 2022-02-24 | 繰り返されました | Stifel | Buy |
| 2022-02-24 | 繰り返されました | Wells Fargo | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-11 | 開始されました | Stifel | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-06-12 | 開始されました | BTIG Research | Buy |
| 2020-02-21 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-08-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-04-10 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 繰り返されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | JP Morgan | Overweight |
| 2018-10-29 | 開始されました | William Blair | Outperform |
すべてを表示
Guardant Health Inc (GH) 最新ニュース
Insider Selling: Guardant Health (NASDAQ:GH) Insider Sells 55,167 Shares of Stock - MarketBeat
How Guardant Health Inc. (5GH) stock compares with top peers2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
How supply shortages influence Guardant Health Inc. (5GH) stock2025 Key Lessons & Safe Capital Allocation Plans - Newser
Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Guardant Health Inc. (5GH) stock a fit for income portfoliosMarket Volume Summary & Free Technical Pattern Based Buy Signals - Newser
Will Guardant Health Inc. stock deliver long term returnsJuly 2025 Catalysts & Detailed Earnings Play Strategies - Newser
Guardant Health Insider Sold Shares Worth $5,846,163, According to a Recent SEC Filing - marketscreener.com
Guardant Health (GH) chief people officer sells $5.8m in stock By Investing.com - Investing.com Canada
Guardant Health (GH) chief people officer sells $5.8m in stock - Investing.com UK
BioMark Diagnostics receives Innovation Award for lung cancer screening project - Mugglehead Magazine
Why Guardant Health (GH) Stock Is Up Today - Finviz
Guardant Health Stock Surges 46% In A Single Month, Wait For A Dip To Buy The Stock - Trefis
What RSI levels show for Guardant Health Inc. (5GH) stockJuly 2025 Recap & Community Verified Trade Signals - Newser
Legal & General Group Plc Has $8.23 Million Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. $GH Shares Sold by Granite Investment Partners LLC - MarketBeat
Morgan Stanley Raises Price Target for Guardant Health (GH) to $130 | GH Stock News - GuruFocus
Morgan Stanley Raises Price Target on Guardant Health to $130 From $105, Keeps Overweight Rating - marketscreener.com
Will Guardant Health Inc. (5GH) stock gain from green policiesEntry Point & Step-by-Step Swing Trade Plans - Newser
Is Guardant Health Inc. (5GH) stock nearing a technical breakoutWeekly Trade Recap & Weekly Return Optimization Alerts - Newser
Sen. Sheldon Whitehouse Purchases Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
GUARDANT HEALTH INC (1GH.MI) options chain - Yahoo Finance UK
GUARDANT HEALTH INC (1GH.MI) interactive stock chart - Yahoo Finance UK
GUARDANT HEALTH INC (1GH.MI) analyst ratings, estimates and forecasts - Yahoo Finance UK
GUARDANT HEALTH INC (1GH.MI) income statement - Yahoo Finance UK
How Guardant Health Inc. stock trades during market volatilityOil Prices & Risk Managed Investment Signals - Newser
Colon Cancer Screenings: What you need to know - News Channel 5 Nashville
Wells Fargo Initiates Coverage of Guardant Health (GH) with Overweight Recommendation - MSN
Guardant Health, Inc. $GH Shares Sold by Swiss National Bank - MarketBeat
Prudential Financial Inc. Sells 8,850 Shares of Guardant Health, Inc. $GH - MarketBeat
Guardant Health Inc Stock Analysis and ForecastPrice Action Analysis & Best Stocks For Explosive Growth - earlytimes.in
(GH) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Pre-Dx Oncology Market Outlook 2026–2035: A Strategic Insight by Towards Healthcare - GlobeNewswire Inc.
Handelsbanken Fonder AB Has $1.54 Million Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Collaborates with Zephyr AI to Enhance Oncology Research - Digital Health News
Middle East Liquid Biopsy Market Size | Industry Report, 2033 - Grand View Research
Will Guardant Health Inc. stock deliver better than expected guidanceJuly 2025 Gainers & Long Hold Capital Preservation Plans - BỘ NỘI VỤ
Guardant Health (GH): Valuation in Focus After Obamacare Subsidy Extension Proposal Spurs Stock Surge - Yahoo Finance
How Recent Developments Are Shaping the Guardant Health Investment Story - Yahoo Finance
Guardant Health, Inc. (GH) Stock Forecasts - Yahoo Finance
Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - Finviz
Tumor Blood Testing Market Projections 2025-2032: Key Trends, - openPR.com
Guardant Health (GH): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - Yahoo Finance
What risks investors should watch in Guardant Health Inc. stock2025 Price Targets & Real-Time Price Movement Reports - newser.com
Guardant Health director Tariq Musa sells $11,165 in stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: Musa Tariq Sells Shares of Guardant Health I - GuruFocus
Is Guardant Health Inc. (5GH) stock in buy zone after pullbackJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com
Guardant Health director Tariq Musa sells $11,165 in stock - Investing.com
Guardant Health Director Tariq Musa Sells Shares - TradingView
Guardant Health Inc (GH) 財務データ
収益
当期純利益
現金流量
EPS
0.86%
1.61%
大文字化:
|
ボリューム (24 時間):